HYF
Immunoprecise Antibodies (HYFT) Q1 2025 Earnings
HYFT·Reported March 28, 2025·Before market open
Immunoprecise Antibodies reported Q1 2025 revenue of $4.2M, missed analyst consensus of $7.9M by $3.7M. Diluted EPS came in at $-0.06.
Revenue
$4.2Mmissed by $3.7M
Consensus: $7.9MDiluted EPS
$-0.06met estimate
Consensus: $-0.06
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about Immunoprecise Antibodies's Q1 2025 earnings report.
Immunoprecise Antibodies (HYFT) reported Q1 2025 earnings on March 28, 2025 before market open.
Immunoprecise Antibodies reported revenue of $4.2M and diluted EPS of $-0.06 for Q1 2025.
Revenue missed the consensus estimate of $7.9M by $3.7M. EPS beat the consensus estimate of $-0.06 by $0.00.